Laboratory Medicine ›› 2016, Vol. 31 ›› Issue (7): 632-635.DOI: 10.3969/j.issn.1673-8640.2016.07.022
• Orginal Article • Previous Articles
Received:2015-07-04
Online:2016-07-30
Published:2016-08-10
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2016.07.022
| 1 | ANDERSSON PO,RIDELL B,WADENVIK H,et a1. Leukemic transformation of essential thrombocythemia without previous cytoreductive treatment[J]. Ann Hematol,2000,79(1):40-42. |
| 2 | 蓝海峰,方志鸿,张悦,等. 438例原发性血小板增多症的临床分析[J]. 中华血液学杂志,2008,29(9):587-591. |
| 3 | 陆米则,李建勇,段丽敏,等. 原发性血小板增多症的细胞遗传学特征[J]. 实用临床医药杂志,2006,10(9):25-27. |
| 4 | BENCH AJ,NACHEVA EP,CHAMPION KM,et al. Molecular genetics cytogenetics of myeloproliferative disorders[J]. Baillieres Clin Haematol,1998,11(4):819-848. |
| 5 | Report on essential thrombocythemia[J]. Cancer Genet Cytogenet,1981,4(2):138-142. |
| 6 | 晁红颖,范峥,张日,等. 412例骨髓增殖性肿瘤的JAK2V617F突变检测及其临床意义[J]. 中华肿瘤杂志,2009,31(7):510-514. |
| 7 | PANANI AD. Cytogenetic and molecular aspects of Philadelphia negative chronic myeloproliferative disorders:clinical implications[J]. Cancer Lett,2007,255(1):12-25. |
| 8 | SESSAREGO M,DEFFERRARI R,DEJANA AM,et al. Cytogenetic analysis in essential thrombocythemia at diagnosis and at transformation. A 12-year study[J]. Cancer Genet Cytogenet,1989,43(1):57-65. |
| 9 | GANGAT N,TEFFERI A,THANARAJASINGAM G,et a1. Cytogenetic abnormalities in essential thrombocythemia:prevalence and prognostic significance[J]. Eur J Haematol,2009,83(1):17-21. |
| 10 | JAMES C,UGO V,LE COUEDIC JP,et a1. A unique clonal JAK2 mutation leading to constitutive signaling causes polycythaemia vera[J]. Nature,2005,434(7037):1144-1148. |
| 11 | LEVINE RL,WADLEIGH M,COOLS J,et a1. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera,essential thrombocythemia,and myeloid metaplasis with myelofibrosis[J]. Cancer Cell,2005,7(4):387-397. |
| 12 | KRALOVICS R,PASSAMONTI F,BUSER AS,et a1. A gain-of-function mutation of JAK2 in myeloproliferative disorders[J]. N Engl J Med,2005,352(17):1779-1790. |
| 13 | ROSSI D,DEAMBROGI C,CAPELLO D,et a1. JAK2 V617F mutation in leukaemic transformation of philadelphia-negative chronic myeloproliferative disorders[J]. Br J Haematol,2006,135(2):267-268. |
| 14 | THEOCHARIDES A,BOISSINOT M,GIRODON F,et a1. Leukemic blasts in transformed JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation[J]. Blood,2007,110(1):375-379. |
| 15 | 禹文君,陈丽娟,李建勇,等. JAK2 V617F突变阳性原发性血小板增多症转化为JAK2 V617F突变阴性急性髓系白血病一例报告并文献复习[J]. 中华血液学杂志,2014,35(12):1122-1123. |
| [1] | DENG Chenxia, MEI Yanping, ZHANG Xia, HUANG Baoshan, TIAN Dan, CAO Mengting, HU Yongqi, LIN Yongping, TIAN Lijun. Depolymerization effect of optical platelet count on reversible platelet aggregation after blood collection [J]. Laboratory Medicine, 2023, 38(11): 1087-1090. |
| [2] | LU Tingyan, GU Danfeng, WANG Yahong, GE Yafang, YANG Haiou. Evaluation of vaginal secretion routine determination modes and review criteria analysis [J]. Laboratory Medicine, 2023, 38(11): 1091-1097. |
| [3] | . [J]. Laboratory Medicine, 2023, 38(11): 1098-1100. |
| [4] | . [J]. Laboratory Medicine, 2023, 38(10): 983-986. |
| [5] | . [J]. Laboratory Medicine, 2023, 38(9): 901-904. |
| [6] | . [J]. Laboratory Medicine, 2023, 38(9): 905-908. |
| [7] | CHENG Xu, YANG Cunqing, PANG Bo, GU Chun, HOU Xueyun, FEI Jiaxin, WU Min, LI Jun, LIU Guijian. Number and activity of peripheral blood eosinophils in obese people [J]. Laboratory Medicine, 2023, 38(9): 855-859. |
| [8] | LEI Jing, MAN Qiuhong, ZHAO Renjia, ZHANG Tiejun, JIANG Yanfeng, XU Kelin, SUO Chen, CHEN Xingdong. Elevated red blood cell distribution width increasing the risk of heart failure：a cohort study based on the UK Biobank [J]. Laboratory Medicine, 2023, 38(9): 860-864. |
| [9] | DUAN Lili, JIANG Chang, ZHOU Dongmei. Role of PLR in ankylosing spondylitis patients with positive antinuclear antibody [J]. Laboratory Medicine, 2023, 38(7): 669-674. |
| [10] | XIA Yanyan, XIA Yongquan, SONG Guanghao, XIA Mao. Role of coagulation-related monitoring indicators in the course of rivaroxaban anticoagulation for acute venous thromboembolism in elderly patients [J]. Laboratory Medicine, 2023, 38(5): 475-478. |
| [11] | CHEN Yi, WANG Jia, XU Zhiwei, ZHAI Yaping, XUAN Weixia. Effects of different anticoagulants on phagocytosis，activation and apoptosis of in vitro neutrophil function [J]. Laboratory Medicine, 2023, 38(5): 479-483. |
| [12] | YANG Liyuan, DAI Wanqin, WANG Xiaotong, LOU Xiaoli, WANG Yue, HOU Yanqiang. Effect of peripheral blood neutrophils on interferon-gamma release assay of Mycobacterium tuberculosis [J]. Laboratory Medicine, 2023, 38(5): 484-488. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(5): 502-504. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(1): 69-72. |
| [15] | XIE Yuan, YI Wanwan, SHI Qiuyuan, LÜ Zhongwei, LIU Jin. Clinical value of thromboelastography and conventional coagulation tests in evaluating coagulation status of colon cancer and colon polyps [J]. Laboratory Medicine, 2022, 37(11): 1007-1011. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
